ArticleCancer chemotherapy and pharmacology2012

A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy.

Michael J Pishvaian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.